Spots Global Cancer Trial Database for Sipuleucel-T and Ipilimumab for Advanced Prostate Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Sipuleucel-T and Ipilimumab for Advanced Prostate Cancer
Official Title: Phase 1 Study of Sipuleucel-T and Ipilimumab in Combination for Advanced Prostate Cancer
Study ID: NCT01832870
Study Description
Brief Summary: This is a clinical trial designed to quantify the immune response and determine the tolerability and side effects of sipuleucel-T when given in combination with ipilimumab for patients with advanced prostate cancer.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
Prostate Oncology Specialists, Inc., Marina del Rey, California, United States
Contact Details
Name: Mark Scholz, MD
Affiliation: Prostate Oncology Specialists, Inc.
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
